53613-24-4

Upstream product

• 34404-36-9 Boc-Lys(Z)-OSu 
• 56-40-6 glycine 
• 2389-45-9 Boc-Lys(Z)-OH 
• 5680-79-5 glycine ethyl ester hydrochloride 
• 2389-46-0 N-α-tert-butyloxycarbonyl-N-ε-benzyloxycarbonyl-lysine p-nitrophenyl ester 
• 33043-26-4 N-(N^α-tert-butoxycarbonyl-N^ε-carbobenzoxy-L-lysyl)glycine ethyl ester 
• 23234-35-7 N^α tert-Butyloxycarbonyl-N^ε-carbobenzyloxy-L-lysyl-glycine methyl ester 

Downstream Products

• 112120-69-1 Boc-(Lys(Z)-Gly)2-OMe 
• 1402730-21-5 C₂₃H₃₄N₆O₅ 
• 1402730-18-0 C₂₂H₃₂BrN₃O₆ 
• 1402730-03-3 C₂₃H₃₂N₄O₆ 
• 112120-75-9 Boc-(Lys(Z)-Gly)3-ONSu 
• 112120-73-7 Boc-(Lys(Z)-Gly)3-OMe 
• 112120-74-8 Boc-(Lys(Z)-Gly)3-OH 
• 112097-72-0 cyclo(-Lys(Z)-Gly-)3 
• 112120-72-6 TFA*H-(Lys(Z)-Gly)3-ONp 
• 112120-77-1 TFA*H-(Lys(Z)-Gly)3-ONSu 
• 112120-79-3 TFA*H-(Lys(Z)-Gly)3-OH 
• 112120-70-4 Boc-(Lys(Z)-Gly)3-ONp 
• 68803-04-3 Boc-(Lys(Z)-Gly)2-OH 
• 149992-28-9 N-α-tert-butyloxycarbonyl-N-ε-benzyloxycarbonyl-lysyl-glycylasparaginyl-tyrosine 

Relevant academic research and scientific papers

Multipurpose isothiocyanyl alanine/lysine: Use as solvatochromic IR probes and in site specific labeling/ligation of short peptides

The solvatochromic IR responsivity of small side chain –NCS in two unexplored unnatural amino acids, isothiocyanyl alanine (NCSAla = Ita) and lysine (NCSLys = Itl), without perturbing the conformation is demonstrated in two designed

Design of high-affinity peptide conjugates with optimized fluorescence quantum yield as markers for small peptide transporter PEPT1 (SLC15A1)

We employed a computational approach to design and synthesize a series of fluorescently labeled hPEPT1 substrates. Five Alexa Fluor-350-labeled peptides were assessed for their in vitro inhibitory activity in hPEPT1-transfected CHO cells. At least four labeled peptides show potent inhibitory activity toward hPEPT1-mediated uptake of [3H]-GlySar and three compounds displayed a significant cellular uptake specifically mediated by hPEPT1.

Synthesis and angiotensin converting enzyme inhibitory activity of L-lysyl-N-substituted glycine derivatives

The synthesis and biological activity of novel L-lysyl-N-substituted glycine derivatives which exhibit in vitro and in vivo angiotensin converting enzyme (ACE) inhibition, are described. Particularly, N-[N(α)-(1-carboxy-3-phenylpropyl)-L-lysyl]-N-(4-pheny